Nancy Sacco, Ph.D.
Vice President, Clinical Development
Nancy Sacco joined AnaptysBio in August 2018 with 20+ years of pharmaceutical experience through all phases of Clinical Development and product registration. Prior to AnaptysBio, Nancy led Clinical Operations globally at Revance, Avexis and Takeda, overseeing clinical trials across aesthetics, neuromuscular and psychiatric disorders, metabolic disease, women’s health, infectious diseases/immunology, oncology, and gene therapy/rare disease. She has held operational and leadership roles with increasing responsibilities at P&G, Warner Lambert and Pfizer on teams including Risedronate, Lyrica, Rozerem, Alogliptin, Xtandi, Myrbetriq and Cresemba. As ExecDir Strategic Operations, she led the Global Drug Development operating model implemented at across Astellas US, Eu and Japan and represented Astellas on both Transcelerate and AVOCA consortia. Nancy received a BS Biology from Fairfield University, MS and PhD from WVU School of Medicine in Morgantown and completed a postdoctoral fellowship at Loyola Stritch School of Medicine focusing on effects of cytokines and metabolic disease.